Cabozantinib, Vandetanib, Pralsetinib and Selpercatinib as Treatment for Progressed Medullary Thyroid Cancer with a Main Focus on Hypertension as Adverse Effect

por Højer Wang, Linnea, Wehland, Markus, Wise, Petra M., Infanger, Manfred, Grimm, Daniela, Kreissl, Michael C.
Publicado 2023